Navigation Links
Starfish Ventures Closes Australia's Largest Venture Capital Fund With $185 Million Tech Fund

MELBOURNE, Australia, Nov. 12 /PRNewswire/ -- Melbourne-based Starfish Ventures announced today the successful closure of its Starfish Technology Fund II at $185 million, the largest venture capital fundraising in Australia. The fund will invest in ICT, Life Sciences and Cleantech companies.

The success of this fundraising is an endorsement of Starfish Ventures and an endorsement of Australia's ability to foster the development of innovative companies that, with the right support, can be transformed into successful global businesses. The current fund brings Starfish's funds under management to more than $385 million.

Investments in Starfish Technology Fund II include Ausra, Aruspex, Monitoring Division and Pro-Active Medical, and all investors in the current fund were also investors in the prior fund -- evidence, according to Starfish Investment Principal, Michael Panaccio, of the company's strong record of success in backing innovative companies with the potential to become global leaders.

Starfish Ventures has announced the closure of its fundraising for Starfish Technology Fund II at $185 million -- the largest venture capital fundraising in Australia -- bringing total funds under management to more than $385 million. Starfish Technology Fund II will focus on Information and Communications Technology, Life Sciences and Cleantech.

Seven investments have been made under Starfish Technology Fund II to date:
Cleantech: Myriax and Ausra

ICT: 5th Finger, Aruspex , Monitoring Division, and Ofidium

Life Sciences: Pro-Active Medical

"Starfish is pleased to raise $185 million for Starfish Technology Fund II in what has turned out to be a difficult fundraising environment," said Dr. Panaccio, Starfish Ventures Investment Principal, "We're delighted that the Starfish Technology Fund II investors were also investors in our previous fund."

"Starfish Ventures will continue to build on our past successes, such as Distra, Engana and ImpediMed, all of which have successfully created new global markets. We are committed to continue partnering with great management teams to transform innovative Australian technology into great global businesses."



-- Myriax: Produces high quality aquaculture technology and environmental

data analysis and visualization software.

-- Ausra: A solar thermal energy company providing solar power, steam and

energy systems for industrial processes and utility-scale electricity


Information and Communications Technology

-- 5th Finger: Develops mobile marketing technology for the creation,

management and execution of marketing campaigns on mobile devices.

-- Aruspex: Delivers strategic workforce planning solutions that help

organisations design and attain their future workforce.

-- Monitoring Division: Develops technology for identifying and monitoring

multiple network impairments in optical networks.

-- Ofidium: Develops 100Gps optical transceiver modules to increase the

speed of transmissions to optical networks.

Life Sciences

-- Pro-Active Medical: Develops a medical device for the monitoring of

lower back movement and a feedback device for poor posture.

Media contacts:

Asia/USA Susan Fitzpatrick +61 (0) 400246010

Office +1 650 7985238/+61 (0) 290061614

Australia: Tania Ewing 0408378422

Office: 02 90061614

SOURCE Starfish Ventures
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Hank Plain Joins Morgenthaler Ventures as Partner
2. Dan Broderick Joins Prolog Ventures as Partner
3. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
4. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
5. Khosla Ventures and BIOeCON Form KiOR Inc.
6. Jerusalem Global Ventures Announces $200 Million Growth Equity Fund
7. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
8. Clarus Ventures Closes $660 Million Fund
9. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
10. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
11. SPO Medical Retains American Capital Ventures for Investor Relations Services
Post Your Comments:
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology:
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):